GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Gsk (GSK) posted Return on Capital Employed [ROCE] of 3.36% for the quarter ended Jun 30, 2026, down 2.96 percentage points from 6.32% a year earlier and down 1.80 percentage points from the prior quarter.

Analysis

Gsk (GSK) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Gsk's Return on Capital Employed [ROCE] came in at 9.82%, up 4.80 percentage points from the prior year.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +3.96 percentage points (years ended Dec 2020 to Dec 2025).
  • In prior years, Gsk's Return on Capital Employed [ROCE] was 5.02% in the year ended Dec 31, 2024 (-3.36 pp), 8.38% in the year ended Dec 31, 2023 (+1.74 pp), 6.64% in the year ended Dec 31, 2022 (+2.32 pp) and 4.32% in the year ended Dec 31, 2021 (-1.54 pp).
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Return on Capital Employed [ROCE] since the quarter ended Sep 30, 2016.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -1.28 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was the quarter ended Sep 30, 2025, with a gain of 4.19 percentage points; the weakest was the quarter ended Jun 30, 2022, with a drop of 9.23 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 5.16% (quarter ended Mar 31, 2026), 5.01% (quarter ended Dec 31, 2025) and 9.01% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 17.83%
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 17.92%
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 6.28%
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 19.32%
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 9.54%
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 16.66%
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -5.97%
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 11.86%
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 3.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.36%
Mar 31, 2026 5.16%
Dec 31, 2025 5.01%
Sep 30, 2025 9.01%
Jun 30, 2025 6.32%
Mar 31, 2025 5.85%
Dec 31, 2024 4.92%
Sep 30, 2024 4.82%
Jun 30, 2024 7.19%
Mar 31, 2024 7.84%
Dec 31, 2023 8.28%
Sep 30, 2023 9.48%
Jun 30, 2023 8.76%
Mar 31, 2023 7.80%
Dec 31, 2022 8.23%
Sep 30, 2022 5.59%
Jun 30, 2022 5.23%
Mar 31, 2022 8.23%
Dec 31, 2021 4.31%
Sep 30, 2021 3.15%
API Access

Gsk Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY